CD209 and infection: Interestingly, while the presence of H37RvAE liposomes decreased HIV-1 X4 and R5 trans-infection via DC-SIGN to 0.35 (p-value = 0.0004) and 0.22 efficacy (p-value = 0.0004), H37RvMA did not affect virus capture-transfer with a mean efficacy of 1.09 (HIV-1 X4) and 0.98 (HIV-1 R5).